Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
eli lilly
3
×
indiana blog main
indiana top stories
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
3
×
seattle top stories
startups
3
×
texas blog main
texas top stories
wisconsin blog main
3
×
wisconsin top stories
abbvie
aduro biotech
alexion pharmaceuticals
bristol-myers squibb
clinical trials
deals
What
bio
drug
3
×
roundup
alzheimer’s
companies
price
prices
annual
approval
assessed
attention
biogen’s
biopharmaceutical
biotech
communities
conference
convo
different
earlier
esmo
europe
fail
failures
gene
germany
hosted
increases
investment
latest
littered
munich
nash
new
news
pharmaceutical
plan
prescription
puzzle
raise
remains
Language
Current search:
medicare
×
startups
×
" wisconsin blog main "
×
" seattle blog main "
×
drug
×
" eli lilly "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More